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Abstract

Obstructive apneas produce high negative intrathoracic pressure which imposes an afterload burden on
the left ventricle. Such episodes might produce structural changes in the left ventricle over time.
Doppler echocardiograms were obtained within 2 months of attended polysomnography. Patients were
grouped according to apnea-hypopnea index (AHI): mild/no OSA (AHI < 15) and mod/severe OSA (AHI ≥
15). Mitral valve tenting height and area, left ventricular (LV) long and short axis, and LV end-diastolic
volume (LVEDV), were measured along with tissue Doppler parameters. Comparisons of measurements
at baseline and follow up between and within groups were obtained; correlations between absolute
changes (deltas) in echocardiographic parameters were also performed. After a mean follow up of 240
days mitral valve tenting height increased significantly (1.17 ± 0.12 cm to 1.28 ± 0.17 cm, p=0.001) in
mod/severe OSA as did tenting area (2.30 ± 0.41 cm2 to 2.66 ± 0.60 cm2, p=0.0002); delta tenting height
correlated with delta LVEDV (rho 0.43, p=0.01) and delta tenting area (rho 0.35, p=0.04). In mild/no OSA
patients there was no significant change in tenting height; there was a borderline significant increase in
tenting area (2.20 ± 0.44 cm2 to 2.31 ± 0.43 cm2, p=0.05). Septal E’ decreased (8.04 ± 2.49 cm/sec to
7.10 ± 1.83 cm/sec, p=0.005) in mod/severe OSA subjects, but not in the mild/no OSA group. In
conclusion, in patients with mod/severe OSA, mitral valve tenting height and tenting area increase
significantly over time. This appears to be related, at least in part, to changes in LV geometry.

Running Head: OSA increases mitral valve tenting

Key Words: Mitral valve tenting, obstructive sleep apnea, left ventricular geometry
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Introduction
Obstructive sleep apnea (OSA) has adverse effects on left ventricular (LV) diastolic function 1
and on global LV function 2-4 . However, aside from producing increased wall thickness 2 there is little
information available regarding effects on left heart structure. We tested the hypothesis that moderate
to severe OSA, over time, can lead to changes in mitral valve tenting height and area in association with
changes in LV geometry.

Methods

This prospective longitudinal study recruited subjects from the Sleep Disorders Center at Albert
Einstein Medical Center between January 2008 and May 2010. All had sleep tests ordered on clinical
grounds and none had a previously diagnosed sleep disorder. Exclusions included 1) any evidence of
coronary disease, 2) mitral leaflet disease, and 3) decreased ejection fraction for any reason.
Demographic and clinical data were collected but no attempt was made to control medical therapy.
Subjects underwent Doppler echocardiography shortly after polysomnography and again 6 months or
more after the initial study. For those prescribed continuous positive airway pressure, compliance was
measured by interrogation of the device or “smartcard”. Because only 4 subjects were compliant (> 4
hours/night), the current paper reflects the natural history of untreated severe OSA.
Polysomnography was performed utilizing the VIASYS SomnoStar Pro Sleep System (SomnoStar
Software 9-1b). The electroencephalogram, electro-oculogram, and electromyogram were monitored
for sleep staging. Nasal pressure monitoring, chest wall movement, abdominal movement, snoring and
oxygen saturation were recorded for respiratory assessment. The electrocardiogram and tibial
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electromyogram were monitored for cardiac arrhythmias and nocturnal limb movements respectively.
Studies were interpreted according to the standards of the American Academy of Sleep Medicine5.
Presence and severity of OSA were established based on apnea-hypopnea index (AHI) : <5 = no OSA, ≥ 5
AHI < 15 = mild OSA, ≥ 15 AHI < 30 = moderate OSA, and AHI≥ 30 = severe OSA. Interpretation of all
polysomnograms was performed by board certified sleep medicine physicians.

Two-dimensional and Doppler echocardiography were performed according to American Society
of Echocardiography standards 6. Mitral valve tenting area was measured in mid-systole in the
parasternal long-axis view as the area bounded by the closed mitral leaflets and a line connecting the
annular attachment points of the 2 leaflets. Tenting height was defined as the distance from that line to
the point of coaptation of the leaflets7 (figure 1). Left atrial dimension was measured as the diameter of
the left atrium in systole in the parasternal long-axis view. Left atrial volume was measured in the apical
views according to the biplane area-length method. The LV long axis was measured at end-diastole from
the annular plane to the apex in the 4-chamber view. The LV short axis was measured in the same view
as the diameter of the left ventricle (endocardium to endocardium) at the tips of the open mitral valve
leaflets. LV end diastolic volume (LVEDV) and end systolic volume (LVESV) were measured using the
modified Simpson’s biplane method. The interpapillary muscle distance of the left ventricle was
measured at end-diastole in the parasternal short axis view by drawing a line through the papillary
muscles and measuring between the LV endocardial borders where the papillary muscles attached.
Tissue Doppler measurements included the systolic wave (S’) and early diastolic wave (E’) measured at
the septal and lateral aspects of the mitral valve annulus in the 4-chamber view.

Two experienced, board certified echocardiographers (GSP and VMF) read all the
echocardiograms. In order to avoid interobserver variability, each parameter was measured by only one
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observer (GSP: tenting height, tenting area, LVEDV, LVESV, left atrial dimension, left atrial volume; VMF:
LV long axis, LV short axis, LV interpapillary muscle distance, E’, and S’). Values for each measured
parameter were obtained by averaging a minimum of 3 measurements for that parameter.
Echocardiograms were read in a blinded manner without knowledge of OSA status.

Continuous variables are displayed as mean ± standard deviation and categorical variables are
displayed as numbers and percentages. Paired analyses were used to compare variables within groups
over time. Non-parametric correlations (Spearman) were used to assess the relationship between
absolute changes (deltas) in echocardiographic variables over time in both groups. Two-tailed p values <
0.05 were considered significant in advance. Linear regression was used to assess for univariate
predictors of change in tenting height and tenting area; those variables with p values < 0.10 were
included in multivariate analysis. Multivariate linear regression was used to assess for predictors of
change in tenting height and area after adjustment for variables identified in the univariate analyses; p
values < 0.05 were considered significant. Intraobserver variability was calculated for tenting height and
tenting area, expressed as percentages. All analyses were performed using JMP 8.0 software.

Results

Fifty-four subjects were enrolled and followed for a mean of 240 days (range 180 - 431). Six
patients did not have follow-up echocardiograms (11% of the sample). Baseline characteristics of the
subjects included in the study are displayed in table 1.
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When divided into 2 groups, AHI < 15 (mild/no OSA) and AHI ≥ 15 (mod/severe OSA), baseline
characteristics were similar between groups except for BMI which was higher in the group with
moderate to severe OSA.

Intraobserver variability for the main outcome variables was 4% for tenting height and 6% for
tenting area. Baseline Doppler echocardiographic variables for the 2 AHI groups are presented in table
2. Only lateral E’ differed significantly between groups (p = 0.05). Table 3 presents Doppler
echocardiographic variables over time stratified by AHI groups. Of note, among those with mod/severe
OSA, tenting height increased over time (p = 0.001; figure 2a) as did tenting area (p = 0.0002; figure 2b).
In the group with mild/no OSA there was no significant change in tenting height while a borderline
significant increase in tenting area (p = 0.05) was observed. Septal E’ decreased significantly among
mod/severe OSA, with no significant change noted in those with mild/no OSA.

We also performed correlations within the 2 AHI groups to test whether changes in tenting
height and tenting area were dependent on changes in LV geometry. No significant correlations were
found in the mild/no OSA group. However, among mod/severe OSA subjects, delta tenting height had a
positive and significant correlation with delta LV long axis (rho 0.39, p=0.02), delta LV short axis (rho
0.36, p=0.03), and delta LVEDV (rho 0.43, p=0.01; figure 3). A positive and significant correlation
between delta tenting area and delta LVEDV (rho 0.35, p=0.04) was also observed; however, delta LV
long axis and delta LV short axis showed nonsignificant, though positive, correlations.

Linear regression analysis assessing for univariate predictors of change in tenting height showed
only AHI to be a significant predictor (F ratio 3.83, p = 0.05). Furthermore, AHI remained a significant
predictor of tenting height on multivariate analysis (F ratio 3.93, p = 0.04) after adjustment for age,
Page 7 of 14

gender, race, BMI and hypertension. No significant predictors were found for tenting area (p > 0.10 for
each variable).

It should be noted that, despite changes in tenting height an area over time, no subject
developed significant mitral regurgitation.

Discussion

The main finding of this study is that tenting height and tenting area increased significantly over
time in patients with moderate to severe OSA. This appeared to be related, in part, to remodeling of the
left ventricle. Obstructive apneas impose an afterload burden on the heart8-10 and can occur hundreds
of times per night. The cumulative effects of this pathophysiology, over months to years, might account
for changes in mitral valve tenting and LV chamber dimensions.

It is generally accepted that changes in ventricular shape can produce changes in tenting height
and tenting area. In disease states that produce LV dilation, tenting is associated with outward and
apical displacement of the papillary muscles and often produces clinically significant mitral regurgitation
7,11,12

. In this setting, the ventricle assumes a more spherical shape. Changes in LV geometry are also

commonly seen in athletes although associated mitral regurgitation has not been reported. As opposed
to disease states, ventricular shape appears to be maintained in athletes though chamber dimensions
increase 13-16. The current data suggest similar changes in LV geometry in patients with moderate to
severe OSA.
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The finding that OSA increases mitral valve tenting is potentially important in several ways.
While none of our subjects developed clinically significant mitral regurgitation, it is conceivable that
such might develop over a longer time period. The current study excluded subjects with dilated
ventricles and associated mitral regurgitation. It may be that OSA worsens pre-existing mitral
regurgitation by increasing tenting. It is also possible that significant mitral regurgitation only occurs
during obstructive episodes when blood pressure and afterload are high. Our group has shown that
following an apneic episode (simulated by the Mueller maneuver), there is a compensatory increase in
blood flow to the left side of the heart, which could augment transient mitral regurgitation. 9 In fact,
most episodes of acute pulmonary edema, where mitral regurgitation may be an important contributing
factor, occur at night.

Few previous studies have looked at effects of OSA on LV geometry. Nearly all are observational
and cross-sectional in nature. Dursunoglu et al measured end diastolic dimension by M-mode
echocardiography in 67 subjects with OSA who had no cardiac disease 17. They found a non-significant
trend towards higher values as AHI increased. Drager et al studied 60 patients with hypertension and/or
OSA in whom other disorders were carefully excluded 18. Comparing normotensive subjects with OSA to
controls, they found no significant difference in LV end diastolic dimension between groups. However,
in another study of OSA and hypertension, Myslinski et al observed significantly higher values of LV end
diastolic dimension in OSA subjects with adequately treated hypertension when compared with controls
19

.

In addition to changes in mitral valve tenting, this study documented a decrease over time in the
tissue Doppler parameter E’ among those with moderate to severe OSA. This is consistent with previous
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reports 1,2,20. It is important as decreased E’ is a marker of worsening of global LV diastolic function,
which in turn is associated with heart failure, pulmonary hypertension, and atrial fibrillation.

This study involved a small number of patients and the findings need to be reproduced in a
larger sample. None of the subjects developed significant mitral regurgitation and any connection
between LV remodeling, tenting height and area, and development of future mitral regurgitation
remains speculative. However, increases in tenting height and area have been strongly associated with
mitral regurgitation in diseased ventricles. In addition, these studies were carried out in conscious
subjects. It is possible that mitral regurgitation occurs during an obstructive apnea but not in the waking
state. One of the limitations of OSA research generally, is the difficulty in imaging the heart during an
obstructive apnea.

Our study sample was largely minority and thus our findings might not apply to the general
population. However, there is no reason to believe that the findings would vary by race or ethnicity.
More likely, they are the result of the physiologic perturbations associated with obstructive sleep apnea.

The major strengths of this study are its prospective nature and the blinded interpretation of
the echocardiograms. In addition, the increases in mitral valve tenting height and tenting area were
associated with changes in LV geometry which could plausibly explain them.
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Figure Legends

Figure 1. Parasternal long axis view in midsystole. The mitral valve tenting area is measured by
drawing a line connecting the annular attachment points of the mitral leaflets and then tracing the
leaflet borders. In this case the tenting area is 2.1 cm2 (measurement algorithm also indicates the length
of the border, 8.0 cm). The tenting height is measured by drawing a perpendicular line from the annular
line to the point of leaflet coaptation, in this case 1.3 cm.

Figure 2. Mitral valve tenting height (2a) and tenting area (2b) at baseline and at follow-up in the
mild/no OSA and mod/severe OSA groups. Both variables are seen to increase significantly over time in
the mod/severe OSA group.

Figure 3. Scatterplot of change in mitral valve tenting height as a function of change in left ventricular
end diastolic volume (biplane modified Simpson’s method). Rho = 0.42 indicating a good correlation and
suggesting that change in left ventricular end diastolic volume accounts for at least some of the change
in mitral valve tenting height.
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